Boris Betz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Boris Betz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Michael Kiehntopf
Institute of Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, Jena, Germany
2 shared publications Andreas Stallmach
Department of Internal Medicine IV, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany
1 shared publicationAndré Scherag
Institute of Medical Statistics, Computer and Data Sciences (IMSID), Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany
1 shared publicationChristof Kloos
Department of Internal Medicine III, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany
1 shared publicationChristoph Weber
Department of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany
1 shared publication- Christoph Weber
Department of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena University Hospital, 07747 Jena, Germany
1 shared publication
Latest Publications
- Open Access
- 26 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 24, 724-733
Automated sample annotation for diabetes mellitus in healthcare integrated biobanking
Healthcare integrated biobanking describes the annotation and collection of residual samples from hospitalized patients for research purposes. The central idea of the current work is to establish an automated workflow for sample annotation, selection and storage for diabetes mellitus. This is challenging due to incomplete data at the time of sample selection. The study evaluates a machine learning (ML) and natural language processing (NLP) based two-step procedure for timely and precise sample annotation for diabetes mellitus. Electronic health record data of 785 persons were extracted from the hospital information system. In the first step, a conditional inference forest (CIF) model was trained and tested based on laboratory values from the first 72 h of the hospital stay using test- (n = 550) and training data sets (n = 235). Performance was compared with a simple laboratory cut-off classifier (LCC) and a logistic regression (LR) model. Algorithms based on laboratory values, ICD-10 codes or information from discharge summaries extracted by a natural language processing software (NLP-DS) were evaluated as a second (review) step designed to increase the precision of annotations. For the first step, recall/precision/F1-score/accuracy were 71 %/86 %/0.78/0.82 for CIF and 77 %/70 %/0.74/0.75 for LR compared to 73 %/68 %/0.70/0.72 for LCC. NLP-DS was the best-performing second (review) step (93 %/100 %/0.97/0.97). Combining first-step models with NLP-DS increased precision to 100 % for all procedures (66 %/100 %/0.80/0.85 for CIF&NLP-DS, 72 %/100 %/0.84/87.2 for LR&NLP-DS and 66 %/100 %/0.80/0.85 for LCC&NLP-DS). The number of samples removed by NLP-DS was higher for LR&NLP-DS and LCC&NLP-DS (removal rate 35 % and 38 % of initially selected samples) compared to CIF&NLP-DS (removal rate of 20 %). The developed two-step procedure is an efficient implementable method for timely and precise annotation of samples from diabetic hospitalized patients.
- 26 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 24, 724-733
Open AccessAutomated sample annotation for diabetes mellitus in healthcare integrated biobanking
Healthcare integrated biobanking describes the annotation and collection of residual samples from hospitalized patients for research purposes. The central idea of the current work is to establish an automated workflow for sample annotation, selection and storage for diabetes mellitus. This is challenging due to incomplete data at the time of sample selection. The study evaluates a machine learning (ML) and natural language processing (NLP) based two-step procedure for timely and precise sample annotation for diabetes mellitus. Electronic health record data of 785 persons were extracted from the hospital information system. In the first step, a conditional inference forest (CIF) model was trained and tested based on laboratory values from the first 72 h of the hospital stay using test- (n = 550) and training data sets (n = 235). Performance was compared with a simple laboratory cut-off classifier (LCC) and a logistic regression (LR) model. Algorithms based on laboratory values, ICD-10 codes or information from discharge summaries extracted by a natural language processing software (NLP-DS) were evaluated as a second (review) step designed to increase the precision of annotations. For the first step, recall/precision/F1-score/accuracy were 71 %/86 %/0.78/0.82 for CIF and 77 %/70 %/0.74/0.75 for LR compared to 73 %/68 %/0.70/0.72 for LCC. NLP-DS was the best-performing second (review) step (93 %/100 %/0.97/0.97). Combining first-step models with NLP-DS increased precision to 100 % for all procedures (66 %/100 %/0.80/0.85 for CIF&NLP-DS, 72 %/100 %/0.84/87.2 for LR&NLP-DS and 66 %/100 %/0.80/0.85 for LCC&NLP-DS). The number of samples removed by NLP-DS was higher for LR&NLP-DS and LCC&NLP-DS (removal rate 35 % and 38 % of initially selected samples) compared to CIF&NLP-DS (removal rate of 20 %). The developed two-step procedure is an efficient implementable method for timely and precise annotation of samples from diabetic hospitalized patients.
- Open Access
- 12 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (9) , 2955
Optimized Identification of Advanced Chronic Kidney Disease and Absence of Kidney Disease by Combining Different Electronic Health Data Resources and by Applying Machine Learning Strategies
Automated identification of advanced chronic kidney disease (CKD ≥ III) and of no known kidney disease (NKD) can support both clinicians and researchers. We hypothesized that identification of CKD and NKD can be improved, by combining information from different electronic health record (EHR) resources, comprising laboratory values, discharge summaries and ICD-10 billing codes, compared to using each component alone. We included EHRs from 785 elderly multimorbid patients, hospitalized between 2010 and 2015, that were divided into a training and a test (n = 156) dataset. We used both the area under the receiver operating characteristic (AUROC) and under the precision-recall curve (AUCPR) with a 95% confidence interval for evaluation of different classification models. In the test dataset, the combination of EHR components as a simple classifier identified CKD ≥ III (AUROC 0.96[0.93–0.98]) and NKD (AUROC 0.94[0.91–0.97]) better than laboratory values (AUROC CKD 0.85[0.79–0.90], NKD 0.91[0.87–0.94]), discharge summaries (AUROC CKD 0.87[0.82–0.92], NKD 0.84[0.79–0.89]) or ICD-10 billing codes (AUROC CKD 0.85[0.80–0.91], NKD 0.77[0.72–0.83]) alone. Logistic regression and machine learning models improved recognition of CKD ≥ III compared to the simple classifier if only laboratory values were used (AUROC 0.96[0.92–0.99] vs. 0.86[0.81–0.91], p < 0.05) and improved recognition of NKD if information from previous hospital stays was used (AUROC 0.99[0.98–1.00] vs. 0.95[0.92–0.97]], p < 0.05). Depending on the availability of data, correct automated identification of CKD ≥ III and NKD from EHRs can be improved by generating classification models based on the combination of different EHR components.
- 12 September 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (9) , 2955
Open AccessOptimized Identification of Advanced Chronic Kidney Disease and Absence of Kidney Disease by Combining Different Electronic Health Data Resources and by Applying Machine Learning Strategies
Automated identification of advanced chronic kidney disease (CKD ≥ III) and of no known kidney disease (NKD) can support both clinicians and researchers. We hypothesized that identification of CKD and NKD can be improved, by combining information from different electronic health record (EHR) resources, comprising laboratory values, discharge summaries and ICD-10 billing codes, compared to using each component alone. We included EHRs from 785 elderly multimorbid patients, hospitalized between 2010 and 2015, that were divided into a training and a test (n = 156) dataset. We used both the area under the receiver operating characteristic (AUROC) and under the precision-recall curve (AUCPR) with a 95% confidence interval for evaluation of different classification models. In the test dataset, the combination of EHR components as a simple classifier identified CKD ≥ III (AUROC 0.96[0.93–0.98]) and NKD (AUROC 0.94[0.91–0.97]) better than laboratory values (AUROC CKD 0.85[0.79–0.90], NKD 0.91[0.87–0.94]), discharge summaries (AUROC CKD 0.87[0.82–0.92], NKD 0.84[0.79–0.89]) or ICD-10 billing codes (AUROC CKD 0.85[0.80–0.91], NKD 0.77[0.72–0.83]) alone. Logistic regression and machine learning models improved recognition of CKD ≥ III compared to the simple classifier if only laboratory values were used (AUROC 0.96[0.92–0.99] vs. 0.86[0.81–0.91], p < 0.05) and improved recognition of NKD if information from previous hospital stays was used (AUROC 0.99[0.98–1.00] vs. 0.95[0.92–0.97]], p < 0.05). Depending on the availability of data, correct automated identification of CKD ≥ III and NKD from EHRs can be improved by generating classification models based on the combination of different EHR components.
- 28 April 2017
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 114 (17) , 300
Effect of the Method for Creatinine Measurement
Haase et al. in their review article conclude that an electronic alert system in acute kidney injury coupled with concrete treatment recommendations, has a positive effect on relevant endpoints (1). With regard to the applicability of these study...
- 28 April 2017
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 114 (17) , 300
Effect of the Method for Creatinine Measurement
Haase et al. in their review article conclude that an electronic alert system in acute kidney injury coupled with concrete treatment recommendations, has a positive effect on relevant endpoints (1). With regard to the applicability of these study...